Supernus Pharmaceuticals
SUPN
#4188
Rank
HK$20.26 B
Marketcap
HK$353.40
Share price
-3.69%
Change (1 day)
23.93%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Cash on Hand

Cash on Hand as of September 2025 : HK$2.18 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company has HK$2.18 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Supernus Pharmaceuticals - Cash on Hand chart (from 2009 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$3.52 B76.91%
2023-12-31HK$1.99 B-44.78%
2022-12-31HK$3.60 B36.09%
2021-12-31HK$2.64 B-19.14%
2020-12-31HK$3.27 B21.18%
2019-12-31HK$2.70 B-3.05%
2018-12-31HK$2.78 B154.81%
2017-12-31HK$1.09 B56.56%
2016-12-31HK$0.69 B44.98%
2015-12-31HK$0.48 B-16.4%
2014-12-31HK$0.57 B-9.53%
2013-12-31HK$0.63 B-7.1%
2012-12-31HK$0.68 B81.96%
2011-12-31HK$0.37 B48.14%
2010-12-31HK$0.25 B-50.66%
2009-12-31HK$0.51 B10.55%
2008-12-31HK$0.46 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
HK$21.53 B 884.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$77.13 B 3,425.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$128.39 B 5,769.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$60.16 B 2,650.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$144.42 B 6,501.93%๐Ÿ‡บ๐Ÿ‡ธ USA